KELLY NIX: Open Payments
NPI 1386659928 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 31 payments from 16 companies in 2025. Trend: 2023 $633 · 2024 $675 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $94 |
| Sumitomo Pharma America, Inc. | 5 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| PFIZER INC. | 3 | $61 |
| ABBVIE INC. | 1 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Exact Sciences Corporation | 2 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: GEMTESA, MOUNJARO, PREVNAR 20, JARDIANCE, QULIPTA, INSPIRE, Cologuard Collection Kit, Veozah.
Industry payments across GA — which companies pay providers there.
